Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Pharmacogenomics|April 28, 2020
Variant discovery using next-generation sequencing and its future role in pharmacogeneticsLaura E Russell, Ute I Schwarz
Pharmacogenetics and Genomics|October 25, 2021
In-vitro characterization of coding variants with predicted functional implications in the efflux transporter multidrug resistance protein 4 (MRP4, ABCC4)Jaymie Mailloux, Samantha Medwid, Amanda Facey, et al.
Cold Spring Harbor Perspectives in Medicine|May 31, 2018
The Role of Next-Generation Sequencing in Pharmacogenetics and PharmacogenomicsUte I Schwarz, Markus Gulilat, Richard B Kim
Pharmacogenetics and Genomics|December 16, 2025
NFIB rs28379954 does not affect CYP2D6-mediated metabolism of prototypical substrates, tamoxifen or solanidineSamantha Medwid, Ute I Schwarz, Richard B Kim
Cancer Chemotherapy and Pharmacology|December 3, 2025
Potential clinical relevance of rare dihydropyrimidine dehydrogenase genetic variants identified using whole-exome NextGen sequencing in cancer patients with severe fluoropyrimidine toxicityElizabeth Cui, Samantha Medwid, Ute I Schwarz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 29, 2026
Role of organic anion transporting polypeptides in pancreatic statin disposition and islet cell function in miceChen Bei Hu, Rennian Wang, Rommel G Tirona, et al.
Clinical Pharmacology and Therapeutics|January 25, 2003
Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjectsGeorge K Dresser, Ute I Schwarz, Grant R Wilkinson, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 30, 2016
Genetic Determinants of Clozapine-Induced Metabolic Side EffectsKamini Vasudev, Yun-Hee Choi, Ross Norman, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
DPYD Exon 4 Deletion Associated with Fluoropyrimidine Toxicity and Importance of Copy Number VariationTheodore J Wigle, Samantha Medwid, Cameron Ross, et al.
The American Journal of Geriatric Pharmacotherapy|August 2, 2011
Cytochrome P450 2D6 phenotyping in an elderly population with dementia and response to galantamine in dementia: a pilot studyJo-Anne Clarke, Murray Cutler, Inna Gong, et al.
Pageof 6